Manufacturer Supply, High Purity, Commercial Production
| Chemical Name |
[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride |
| Synonyms |
Rabeprazole Hydroxy Compound; (4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl)methanol Hydrochloride; 4-(3-Methoxypropoxy)-3-Methylpyridine-2-Methanol Hydrochloride |
| CAS Number |
675198-19-3 |
| CAT Number |
RF-PI1919 |
| Stock Status |
In Stock, Production Scale Up to Tons |
| Molecular Formula |
C11H18ClNO3 |
| Molecular Weight |
247.72 |
| Brand |
Ruifu Chemical |
| Item |
Specifications |
| Appearance |
Light Yellow Crystalline Powder |
| Assay / Analysis Method |
>99.5% (HPLC) |
| Loss on Drying |
<0.50% |
| Residue on Ignition |
<0.20% |
| Any Single Impurity |
<0.50% |
| Total Impurities |
<0.50% |
| Heavy Metals |
<20ppm |
| Test Standard |
Enterprise Standard |
| Usage |
Intermediate of Rebeprazole Sodium (CAS: 117976-90-6) |
Rabeprazole Hydroxy Compound CAS 675198-19-3 Synthetic Route
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture
[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride, Rabeprazole Hydroxy Compound, (CAS: 675198-19-3) is an intermediate of Rebeprazole Sodium (CAS: 117976-90-6). Rabeprazole sodium azole canker is a proton pump inhibitor class taking the drugs, for ray Bella azole sodium salt form, first by the Japanese Eisai company successfully developed for the first time, name of commodity for wave force, the role of proton pump inhibitors is to reduce gastric acid secretion of stable disease areas, so as to cure the stomach and duodenal ulcers and stomach esophagus regurgitation disease effect. It is mainly used in clinical treatment of acid-related diseases, such as gastric and duodenal ulcer selection, peptic ulcer, gastroesophageal reflux disease, zhuoye syndrome and so on. Rebeprazole sodium has a faster onset of action compared with omeprazole, but a shorter duration of action. Rabeprazole is a benzimidazole substitute that inhibits gastric acid secretion by binding to the proton pump of gastric parietal cells. This product inhibits the action of adenosine triphosphate, a key enzyme in the production of gastric acid. It can inhibit the secretion of basic gastric acid and gastric acid caused by stimulation.
